PUBLISHER: 360iResearch | PRODUCT CODE: 1598429
PUBLISHER: 360iResearch | PRODUCT CODE: 1598429
Thrombin Market by Type (Bovine Thrombin, Human Plasma Thrombin, Recombinant Thrombin), Form (Liquid, Powder), End-User - Global Forecast 2025-2030
The Thrombin Market was valued at USD 648.96 million in 2023, expected to reach USD 685.05 million in 2024, and is projected to grow at a CAGR of 6.14%, to USD 985.29 million by 2030.
Thrombin, a crucial enzyme for blood coagulation, is extensively utilized in medical procedures to aid in hemostasis. Its primary necessity stems from its role in controlling bleeding, making it indispensable in surgical settings and wound management. The application scope for thrombin spans across various end-uses, from hospitals to specialized surgical centers, and its deployment in biopharmaceutical research adds another dimension. The market for thrombin is influenced by growth factors such as an increase in surgical procedures globally, the rising prevalence of cardiovascular diseases, and advancements in biotechnology that enhance thrombin's efficacy. Emerging opportunities lie in the development of recombinant thrombin and other bioengineered variants, which promise to address allergens and pathogen-transmission challenges associated with traditional forms.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 648.96 million |
| Estimated Year [2024] | USD 685.05 million |
| Forecast Year [2030] | USD 985.29 million |
| CAGR (%) | 6.14% |
However, the market faces limitations, notably the high cost of thrombin production and competition from alternative clotting agents. Regulatory hurdles and stringent safety requirements also pose significant challenges, potentially delaying product approvals and market expansion. There are also concerns about adverse reactions in a subset of patients that can limit its broader application. Despite these challenges, innovation can drive business growth by focusing on molecular modifications to enhance thrombin bioavailability and specificity. Moreover, research into developing thrombin analogs with longer shelf life and stable formulations could open new markets.
The dynamic nature of the thrombin market reflects a blend of matured applications and nascent technological advancements. Recombinant DNA technology represents a promising area for business development, providing a safer and more controlled thrombin variant. To capitalize on market opportunities, businesses should invest in strategic partnerships with biotechnology firms and research institutions, promoting collaborative innovation that aligns with regulatory standards. By understanding these nuances, businesses can better navigate the thrombin market landscape, combining innovative research with strategic foresight to tap into its vast potential while mitigating challenges effectively.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Thrombin Market
The Thrombin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing number of surgical procedures and need for thrombin hemostatic agents
- Expanding utilization of thrombin as a binding agent for meats
- Market Restraints
- Complex production process of thrombin
- Market Opportunities
- Expanding drug development activities promoting the usage of thrombin
- Advancements in the functionalities of thrombin
- Market Challenges
- Major health risks associated with excessive usage of thrombin
Porter's Five Forces: A Strategic Tool for Navigating the Thrombin Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Thrombin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Thrombin Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Thrombin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Thrombin Market
A detailed market share analysis in the Thrombin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Thrombin Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Thrombin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Thrombin Market
A strategic analysis of the Thrombin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Thrombin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc., Bayer AG, BIOFAC A/S, BioMedica Diagnostics Inc., BioPharm Laboratories, LLC, Cayman Chemical, DiaPharma Group, Inc., Grifols, S.A., Johnson & Johnson Services, Inc., Medix Biochemica USA Inc., Merck KGaA, Mochida Pharmaceutical Co., Ltd., MyBioSource, Octapharma AG, Pfizer, Inc., Prolytix, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Regen Lab SA, Rocky Mountain Biologicals, LLC., Shanghai RAAS blood products co., Ltd, Takeda Pharmaceutical Company Limited., Teleflex Incorporated., Thermo Fisher Scientific Inc., and XD BIOCHEMS LIMITED.
Market Segmentation & Coverage
This research report categorizes the Thrombin Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Type, market is studied across Bovine Thrombin, Human Plasma Thrombin, and Recombinant Thrombin.
- Based on Form, market is studied across Liquid and Powder.
- Based on End-User, market is studied across Hospitals & Clinics and Medical Research & Academic Institutes.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing number of surgical procedures and need for thrombin hemostatic agents
- 5.1.1.2. Expanding utilization of thrombin as a binding agent for meats
- 5.1.2. Restraints
- 5.1.2.1. Complex production process of thrombin
- 5.1.3. Opportunities
- 5.1.3.1. Expanding drug development activities promoting the usage of thrombin
- 5.1.3.2. Advancements in the functionalities of thrombin
- 5.1.4. Challenges
- 5.1.4.1. Major health risks associated with excessive usage of thrombin
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Thrombin Market, by Type
- 6.1. Introduction
- 6.2. Bovine Thrombin
- 6.3. Human Plasma Thrombin
- 6.4. Recombinant Thrombin
7. Thrombin Market, by Form
- 7.1. Introduction
- 7.2. Liquid
- 7.3. Powder
8. Thrombin Market, by End-User
- 8.1. Introduction
- 8.2. Hospitals & Clinics
- 8.3. Medical Research & Academic Institutes
9. Americas Thrombin Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Thrombin Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Thrombin Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. Baxter International Inc.
- 3. Bayer AG
- 4. BIOFAC A/S
- 5. BioMedica Diagnostics Inc.
- 6. BioPharm Laboratories, LLC
- 7. Cayman Chemical
- 8. DiaPharma Group, Inc.
- 9. Grifols, S.A.
- 10. Johnson & Johnson Services, Inc.
- 11. Medix Biochemica USA Inc.
- 12. Merck KGaA
- 13. Mochida Pharmaceutical Co., Ltd.
- 14. MyBioSource
- 15. Octapharma AG
- 16. Pfizer, Inc.
- 17. Prolytix
- 18. Prospec-Tany Technogene Ltd.
- 19. Proteintech Group, Inc.
- 20. Regen Lab SA
- 21. Rocky Mountain Biologicals, LLC.
- 22. Shanghai RAAS blood products co., Ltd
- 23. Takeda Pharmaceutical Company Limited.
- 24. Teleflex Incorporated.
- 25. Thermo Fisher Scientific Inc.
- 26. XD BIOCHEMS LIMITED
LIST OF FIGURES
- FIGURE 1. THROMBIN MARKET RESEARCH PROCESS
- FIGURE 2. THROMBIN MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL THROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL THROMBIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL THROMBIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL THROMBIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL THROMBIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL THROMBIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL THROMBIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. THROMBIN MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. THROMBIN MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. THROMBIN MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL THROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. THROMBIN MARKET DYNAMICS
- TABLE 7. GLOBAL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL THROMBIN MARKET SIZE, BY HUMAN PLASMA THROMBIN, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL THROMBIN MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL THROMBIN MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL THROMBIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL THROMBIN MARKET SIZE, BY MEDICAL RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 27. CANADA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 28. CANADA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 29. CANADA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 30. MEXICO THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 33. UNITED STATES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 37. ASIA-PACIFIC THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 41. AUSTRALIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 44. CHINA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 45. CHINA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 46. CHINA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 47. INDIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 48. INDIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 49. INDIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 50. INDONESIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 53. JAPAN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 56. MALAYSIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 59. PHILIPPINES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 62. SINGAPORE THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 65. SOUTH KOREA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. TAIWAN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 71. THAILAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 74. VIETNAM THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 77. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 81. DENMARK THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 84. EGYPT THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 87. FINLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 90. FRANCE THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. GERMANY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 96. ISRAEL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 99. ITALY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 100. ITALY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 101. ITALY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 102. NETHERLANDS THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 105. NIGERIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 108. NORWAY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 111. POLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 112. POLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 113. POLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 114. QATAR THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 115. QATAR THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 116. QATAR THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 117. RUSSIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 120. SAUDI ARABIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 123. SOUTH AFRICA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 126. SPAIN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 129. SWEDEN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 132. SWITZERLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 135. TURKEY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 138. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 141. UNITED KINGDOM THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 144. THROMBIN MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 145. THROMBIN MARKET, FPNV POSITIONING MATRIX, 2023
